Schroder Investment Management Group
ZVRA icon

Schroder Investment Management Group’s Zevra Therapeutics ZVRA Stock Holding History

Schroder Investment Management Group’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.44M Hold
506,033
– – ﹤0.01% 801
2025
Q4 		$4.46M Buy
506,033
+93,486
+23% +$884K ﹤0.01% 766
2025
Q3 		$3.94M Buy
412,547
+97,078
+31% +$974K ﹤0.01% 815
2025
Q2 		$2.78M Buy
+315,469
New +$2.56M ﹤0.01% 865
2016
Q2 		– Sell
-21,419
Closed -$5.14M – 1212
2016
Q1 		$5.14M Hold
21,419
– – 0.01% 691
2015
Q4 		$6.81M Hold
21,419
– – 0.01% 689
2015
Q3 		$6.64M Sell
21,419
-10,969
-34% -$3.36M 0.01% 691
2015
Q2 		$9.52M Buy
+32,388
New +$7.06M 0.02% 650

Other funds holding ZVRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Schroder Investment Management Group's ZVRA Position: Q1 2026 in Review

Schroder Investment Management Group held its Zevra Therapeutics (ZVRA) position steady in Q1 2026 at 506,033 shares worth $4.44M. The position accounts for ﹤0.01% of the portfolio, ranked #801.

Schroder Investment Management Group first reported a position in ZVRA in Q2 2015 and has held it in 8 quarters since. The position peaked at $9.52M in Q2 2015. 148 funds tracked by Wall St. Rank hold ZVRA as of Q1 2026.

  • Schroder Investment Management Group held 506,033 shares of Zevra Therapeutics worth $4.44M as of Q1 2026.
  • Schroder Investment Management Group left its Zevra Therapeutics share count unchanged in Q1 2026.
  • Zevra Therapeutics made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q1 2026, its #801 holding.
  • Schroder Investment Management Group first reported a position in Zevra Therapeutics in Q2 2015 and has held it in 8 quarters since.
  • Schroder Investment Management Group's Zevra Therapeutics position peaked at $9.52M in Q2 2015.
  • 148 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2026.

Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.